Tushar's Stock Tips: Next Multibagger : Himalya International adopted by Reliance Retail

Tuesday, November 20, 2007

Next Multibagger : Himalya International adopted by Reliance Retail

CMP : Rs 23.09

Target: Rs 100 in 15 months

BSE:526899

Business Profile
Himalya International (HIL) was incorporated in the year 1992. The company is promoted by Manmohan Malik and Sanjeev Kakkar. It is engaged in mushrooms and vegetables. The plants of the company are located in Paonta Sahib (Sirmaur, Himachal Pradesh).

The company works in close cooperation with CFTRI (Central Food Technological And Research Institute) located in Mysore, India.

HIL provides variety of products including mushroom products, potato products, dairy products and various products related to this. The company sells its products only in Indian market and in the US market.

It is also certified by the United States Department of Agriculture as a member of National Potato Promotion Board.

The company has a wholly owned subsidiary namely, Global Reliance, which takes care of all the shipment work of the company. It started importing food products from US department of agriculture and will market these products in India.

Financials

Himalya International registered a 91.27% growth in net profits to Rs 25.40 million for the quarter ended in September 2007 from a profit of Rs 13.28 million for the quarter ended in September 2006

Net Sales rose 31.88% to Rs 107.68 million for the quarter ended September 2007 from Rs 81.65 million for the quarter ended September 2006.

Recent Developments
13-NOV-07
Himalya International entered into an agreement with Reliance Retail, the largest retail player in the country, for selling its products in domestic market.

09-NOV-07
Himalya International entered into a contract with Dr. Beyer of State College, Pennsylvania, USA for biological consulting for its mushrooms operations and new plans to augment capacity. Under the contract, the company will be provided with latest technology that will boost mushroom yields from current levels by atleast 50%. Dr. Beyer will be paid fixed fee besides rewards based on increased yields. Dr. Beyer will also assist the company for its mega expansion plans of mushroom facilities.

Future Plans
The company decided to convert 100% EOU into DTA under EPCG scheme of the government of India. It has targeted a turnover of Rs 1,000 million by the year 2010.

In order to meet growing demands of foreign food products in India, the company forayed into importing.

No comments:

Post a Comment

Disclaimer

This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.

The information contained herein is from publicly available data or other sources believed to be reliable. While I would endeavour to update the information herein on reasonable basis, I am under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent me from doing so. I do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. I do not undertake to advise you as to any change of my views. I may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject me to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. I may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. I may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall I or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.